For example, type I interferons (IFN) such as IFN-α, and macrophage migration inhibitory factor (MIF), are cytokines that have been demonstrated in murine and human studies to be implicated in the pathogenesis of SLE, and have been the subject of clinical trials in SLE. This evidence concerns the gene MIF and systemic lupus erythematosus.